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Introduction {#sec1}
============

Alternative pre-mRNA splicing is a powerful mechanism that generates molecular diversity from a limited number of genes and is therefore thought to be essential for biological complexity and diversity in mammals. In particular, the regulation is highly dynamic and complex in the central nervous system (CNS) ([@bib2], [@bib29]). Alternative splicing decisions are known to be dynamically switched during neural development ([@bib21], [@bib49]) and show distinct patterns in a neuronal tissue- or cell type-specific manner ([@bib16], [@bib35], [@bib26], [@bib36]). Furthermore, neuronal activity modulates alternative splicing of neural genes via Ca^2+^-dependent signaling pathways ([@bib37]). Thus, neuronal alternative splicing is dynamically controlled in a spatiotemporal manner, which likely contributes to brain function complexity and diversity ([@bib26], [@bib36]). However, the RNA regulatory mechanisms underlying spatiotemporal and dynamic alternative splicing in neurons are only now being uncovered.

Neuronal alternative splicing is dynamically exerted by regulatory activity and unique expression patterns of RNA-binding proteins (RBPs). We previously identified SAM68 (Src-associated in mitosis of 68-kDa protein, *khdrbs1*) as a critical regulator of neuronal activity-regulated alternative splicing ([@bib18]). Moreover, two related proteins, SLM1 and SLM2 (SAM-like molecule 1 and 2), have been implicated in neuronal cell-type-specific splicing ([@bib11], [@bib17], [@bib35]). SAM68, SLM1, and SLM2 belong to the STAR (signal transduction and activation of RNA) family of proteins, which share 70%--80% of amino acid sequence identities in their KH-type RNA-binding domains ([@bib9]). Important targets of SAM68, SLM1, and SLM2 are the mRNAs encoding Neurexin (*Nrxn*) proteins ([@bib16]). Neurexins are synaptic cell surface receptors extensively regulated at alternative splicing level ([@bib32]). All three STAR family proteins induce skipping of exon 20 at the *Nrxn* alternatively spliced segment 4 (AS4). The splicing decision at AS4 is critical for differential interactions with several ligands that are essential mediators of synaptic properties, including neuroligins, leucine-rich repeat proteins, and the Cbln1-GluD2 complex ([@bib4], [@bib6], [@bib22], [@bib23], [@bib28], [@bib47]). Indeed, the *Nrxn* AS4 is particularly important for synaptic strength and plasticity regulation ([@bib1], [@bib45]), which is dynamically controlled by STAR family proteins in neuronal activity- and cell-type-specific fashions ([@bib11], [@bib18], [@bib17], [@bib35], [@bib45]).

Several groups have previously identified additional substrates for SAM68 and SLM2 ([@bib8], [@bib11], [@bib12], [@bib15], [@bib24], [@bib45]). Knockout mice of SAM68, SLM1, and SLM2 exhibit several morphological and functional defects in adult brains ([@bib12], [@bib18], [@bib17], [@bib27], [@bib45]). We previously found that *Sam68* and *Slm1* ^KO^ mice particularly have cerebellar malformation and motor deficits ([@bib18], [@bib17]). Nevertheless, most neuronal functions of STAR family proteins in the mature brain remain unresolved. However, given that SAM68 and SLM1 are widely expressed in the brain throughout life, spatiotemporal regulation of alternative splicing by SAM68/SLM1 could play a critical role in multiple aspects of neuronal development, differentiation, and function. Thus, the recent findings pave the way to uncover and characterize novel targets for spatiotemporal alternative splicing programs by SAM68/SLM in the nervous system. Here we reveal that SAM68 shapes neuronal diversity of alternative 3′ UTR isoforms and demonstrate the critical role of the SAM68 splicing program in the proper 3′ UTR selection.

Results {#sec2}
=======

Characterization of SAM68/SLM1-Dependent Alternative Splicing Programs {#sec2.1}
----------------------------------------------------------------------

To decipher alternative splicing programs encoded by SAM68 and SLM1 proteins, we attempted to locate new candidate RNA substrates by microarray-based screening using SAM68/SLM1 knockout mice. We utilized the exon array on the primary experiments, the dataset was validated by RT-qPCR, and the altered exons were further confirmed by RNA sequencing (RNA-seq). We previously showed that SLM1 protein acts as a heteromeric complex with SAM68 in co-expressing neurons ([@bib17]). Given that STARs share 70%--80% of amino acid sequence identity in their RNA-binding domains ([@bib9]), it is expected that SAM68 would share a significant amount of RNA substrates with SLM1 with functional redundancy. Therefore, for the initial transcriptomic analysis, we attempted to identify candidate RNA substrates in the midbrain of both SAM68/SLM1 double-knockout (*Sam68*/*Slm1* ^DKO^) mice and SLM1 single-knockout (*Slm1* ^KO^) mice. We focused this analysis on the midbrain because this area is a site of prominent co-expression of SAM68 and SLM1. Initially, we compared the levels of gene expression between wild-type (WT), *Slm1* ^KO^, and *Sam68*/*Slm1* ^DKO^ mice. A scatterplot showed that the gene expression profiles of *Slm1* ^KO^ and *Sam68*/*Slm1* ^DKO^ mice were highly similar to those of WT mice (correlated efficiency: 0.996--0.997) ([Figure S1](#mmc1){ref-type="supplementary-material"}A), indicating that knockout of SAM68 and/or SLM1 did not significantly influence overall transcript levels. In fact, the volcano plots showed that there were only 10--12 genes that are significantly altered in both *Sam68*/*Slm1* ^DKO^ and *Slm1* ^KO^ mice compared with WT (corrected p values \< 0.05; threshold set: fold change \[FC\] ≥ 2.0) ([Figure S1](#mmc1){ref-type="supplementary-material"}B, and [Table S1](#mmc2){ref-type="supplementary-material"}). Validation by RT-qPCR showed that the gene alterations are partially shared between both genotypes ([Figure S1](#mmc1){ref-type="supplementary-material"}C), but others are unique for either SAM68 or SLM1 ([Figure S1](#mmc1){ref-type="supplementary-material"}D). However, *Slm1* transcripts were not listed in the altered genes on the exon array. Although we previously confirmed that SLM1 protein is completely lacking in *Slm1* ^KO^ mice ([@bib17]), the RNA-seq data exhibited that the transcripts lacking exon 2 remain expressed (data not shown). That is why *Slm1* transcripts were not listed in the downregulated genes. Reportedly, SAM68 has multiple functions on RNA metabolism, and a multitude of RNA substrates including non-coding RNAs have been identified using other approaches ([@bib25], [@bib38], [@bib48]). Therefore the very modest number of transcriptomic changes identified in our sample was surprising. The results were largely confirmed by RNA-seq analysis in *Sam68*/*Slm1* ^DKO^ mice (cor. efficiency: 0.986) ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Nevertheless, our results suggest that, even in *Slm1*/*Sam68* double-knocked mice, the effect on total transcript levels is likely to be only minor in the mouse midbrain.

We next examined exon alteration between WT, *Slm1* ^KO^, and *Sam68*/*Slm1* ^DKO^ mice. We observed that 122 and 172 exons were altered by more than 2.4-fold in *Slm1* ^KO^ and *Sam68*/*Slm1* ^DKO^ mice, respectively ([Figure 1](#fig1){ref-type="fig"}A). Given that the whole gene expression profiles were almost unchanged ([Figure S1](#mmc1){ref-type="supplementary-material"}), the majority of the exon alterations were likely due to the change in splicing events. We then compared the altered profiles at the exon level between *Slm1* ^KO^ and *Sam68*/*Slm1* ^DKO^ midbrains. The Venn diagram exhibited that 66 of 228 exons overlapped between the genotypes. We also found that 106 exons were altered only in *Sam68/Slm1* ^DKO^ mice ([Figure 1](#fig1){ref-type="fig"}B). These exons are likely to contain SAM68-specific targets. We also observed that 56 exons were altered only in *Slm1* ^KO^ mice. Indeed, given our previous finding that splicing activity of *Nrxn3* exon20 is quite opposite between the two proteins ([@bib17]), these could also include exons that are regulated differentially between SAM68 and SLM1. Gene ontology (GO) analysis of the altered exons in each genotype showed that major subsets were enriched for similar terms, but those in *Sam68*/*Slm1* ^DKO^ mice were much more enriched for the neuronal terms ([Figure 1](#fig1){ref-type="fig"}C, red terms). Therefore, these results imply that SAM68 and SLM1 encode overlapping but distinct alternative splicing programs.Figure 1Comprehensive Comparison of Altered Exon Profiles between *Slm1*^KO^ and *Sam68/Slm1*^DKO^ MiceTotal RNAs from midbrains of WT, *Slm1*^KO^, and *Sam68/Slm1*^DKO^ mice were subjected to data analyses on exon array (Agilent, Sure Print G3 Mouse Exon Microarray 2x400 K) (n = 3 animals/genotype).(A) Scatterplots showing fold change for exons (*Slm1*^KO^ versus WT, *Sam68/Slm1*^DKO^ versus WT) (total 122 and 172 exons, respectively; threshold set: FC ≥ 2.4, raw probe signal intensity ≥100 in either of the two genotypes, normalized gene expression \> −3 in either of the two genotypes) (n = 3 per genotype) (red and blue dots).(B) Venn diagram showing the numbers of altered exons (total 228 exons; threshold set: FC ≥ 2.4, raw probe signal intensity ≥100 in either of the two genotypes, normalized gene expression \> −3) in both *Slm1*^KO^ and *Sam68/Slm1*^DKO^ mice.(C) Comparison of altered exons by GO analysis between *Slm1*^KO^ and *Sam68/Slm1*^DKO^ mice. Genes that encode altered exons (FC ≥ 2.4) shown in (A) (*Slm1*^KO^: 89 genes; *Sam68*/*Slm1*^DKO^: 112 genes) were subjected to GO analysis. Enrichment was thresholded by p value (p \< 0.05). Red represents the neuronal terms.

The SAM68-Specific Splicing Program Preferentially Regulates Alternative 3′ UTR Exons of Neuronal Genes {#sec2.2}
-------------------------------------------------------------------------------------------------------

To further pursue the potential difference in the splicing program between SAM68 and SLM1, we then classified significantly altered exons into five categories (coding sequence \[CDS\], 5′ untranslated region \[5′ UTR\], 3′ untranslated region \[3′ UTR\], duplicated \[containing both CDS and UTR\], and unknown \[not annotated in refseq\] exons), and compared the relative percentage of each altered exon between *Slm1* ^KO^ and *Sam68*/*Slm1* ^DKO^ mice. Interestingly, we noticed that there was a remarkable difference in the pattern of the exon alteration between *Slm1* ^KO^ and *Sam68*/*Slm1* ^DKO^ mice; 3′ UTR exons were preferentially altered in *Sam68*/*Slm1* ^DKO^ mice ([Figure 2](#fig2){ref-type="fig"}A), although RNA-seq data in *Sam68*/*Slm1* ^DKO^ mice showed that these exon alterations largely included all alternative exon events (i.e., cassette exons, mutually exclusive exons, alternative 5′ splice site, alternative 3′ splice site, and retained introns) ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Indeed, 3′ UTR exons were frequently observed in the top lists of significantly altered exons in *Sam68*/*Slm1* ^DKO^ mice ([Figure 2](#fig2){ref-type="fig"}B). We listed 35 genes whose 3′ UTR exons were significantly altered (threshold set: FC \> 2.4, p \< 0.05) ([Table S2](#mmc3){ref-type="supplementary-material"}). Twenty of 35 genes were unique for *Sam68*/*Slm1* ^DKO^ mice. Importantly, arranged scatterplots of all exons (251 exons) in 35 genes showed that the alteration in 3′ UTR exons likely did not follow the change in their neighboring coding exons within their encoding genes ([Figure 2](#fig2){ref-type="fig"}C), indicating a specific alteration in alternative 3′ UTR isoform choice of these genes.Figure 2Altered 3′ UTR Exon Events Of Neuronal Genes in *Sam68/Slm1*^DKO^ Brains(A) Classification of exons altered in *Slm1*^KO^ and *Sam68/Slm1*^DKO^ mice on exon array datasets. Exons are classified into the following five categories: CDS, 5′ UTR, 3′ UTR, duplicated, and unknown exons. (threshold set: raw probe signal intensity ≥100 in either of the two genotypes, FC ≥ 2.0). The x axis represents the percentage of altered exons per classified exon. Annotation was referenced on Mouse July 2007 (NCBI37/mm9).(B) The list of top 20 list exons that were significantly increased or decreased in *Sam68/Slm1*^DKO^ midbrains (excluding unknown genes and genes including exons altered at the gene level) (threshold set: FC ≥ 2.4, raw probe signal intensity ≥100 in either of the two genotypes, normalized gene expression \> −3 in either of the two genotypes, p \< 0.05 \[compared to WT\]). SKO: *Slm1*^KO^; DKO: *Sam68/Slm1*^DKO^.(C) Arranged scatterplots of all exons (total 251 exons) in 35 genes that include the significantly altered 3′ UTR exons in *Sam68/Slm1*^DKO^ mice. CDS, 5′ UTR, 3′ UTR, duplicated, and unknown exons.(D) GO analyses of genes that include altered 3′ UTR exons in *Sam68/Slm1*^DKO^ mice; 78 genes that include significantly altered 3′ UTR exons (FC ≥ 2.0, p \< 0.05) were subjected to GO analysis. Enrichment was thresholded by p value (p \< 0.05). Keyword category (left). GO-enriched terms (right). Red represents the neuronal terms.(E) Aberrant 3′ UTR exon selection of the representative genes, *Il1rap* and *Cp,* in *Sam68/Slm1*^DKO^ brains shown by RNA-seq (Illumina Hiseq). The alignment of RNA-seq was based on the UCSC genome browser Mouse NCBI37/mm10 assembly.

Interestingly, GO analyses of the altered 3′ UTR exons in *Sam68*/*Slm1* ^DKO^ mice predicted that significant numbers of these targets might include transcripts encoding transmembrane or secreted proteins with neuronal function ([Figure 2](#fig2){ref-type="fig"}D). Intriguing examples were exon 8b of *Il1rap* (interleukin 1 receptor accessory protein, synaptic adhesion protein), exon 26b *of Pcdh15* (protocadherin-15, cell adhesion protein that plays an essential role in maintenance of normal retinal and cochlear function), exon 19 of *Cp* (ceruloplasmin, iron transporter), and exon 4b of *Glra3* (glycine receptor alpha 3, glycinergic ion channel) (see [Figure 2](#fig2){ref-type="fig"}C). Indeed, RNA-seq analysis showed that the proximal 3′ UTR exons of these transcripts were markedly included in *Sam68*/*Slm1* ^DKO^ mice, whereas these were almost excluded in WT mice ([Figures 2](#fig2){ref-type="fig"}E and [S2](#mmc1){ref-type="supplementary-material"}C), resulting in a long-to-short isoform switch of several neuronal targets through alteration in alternative last exon (ALE) selection in *Sam68*/*Slm1* ^DKO^ mice. In addition, because preferential alteration in 3′ UTR exons occurred in *Sam68*/*Slm1* ^DKO^, but not particularly in *Slm1* ^KO^ mice ([Figures 2](#fig2){ref-type="fig"}A and 2B), we hypothesized that the aberrant choice of alternative 3′ UTR isoforms was largely caused by the single-knockout effect of SAM68. To clarify the possibility, the altered 3′ UTR exon events observed in the exon array were validated in *Sam68* ^KO^, *Slm1* ^KO^, and *Slm2* mutant (*Slm2* ^MT^) brains separately by RT-qPCR analysis ([Figure 3](#fig3){ref-type="fig"}). *Slm2* ^MT^ mice expressed SLM2 protein that lacks a first QUA domain ([Figure S3](#mmc1){ref-type="supplementary-material"}), which results in a significant reduction in SLM2 activity toward alternative splicing of *Nrxn* AS4, a major SLM2 target in the brain ([Figures S3](#mmc1){ref-type="supplementary-material"}E and S3F). In this analysis, we focused on eight genes (*Il1rap*, *Cp*, *Pcdh15*, *Lrrcc1*, *Pcdh17*, *Dlgap1*, *Sema3a*, and *Fbxl3*) observed only in *Sam68*/*Slm1* ^DKO^ on the exon array. The RT-qPCR analyses revealed that these exon alterations did not occur in *Slm1* ^KO^ and *Slm2* ^MT^ mice, except for *Fbxl3*, and were specifically caused by single loss of *Sam68* ([Figure 3](#fig3){ref-type="fig"}). The *Sam68* ^KO^-specific alternation included all three types of alternative 3′ UTR splicing events (ALE type \[[Figure 3](#fig3){ref-type="fig"}A\], ALE type with alternative 5′ splice site \[[Figure 3](#fig3){ref-type="fig"}B\], and alternative polyadenylation type \[APA\] \[[Figure 3](#fig3){ref-type="fig"}C\]). Thus, these data show that the SAM68-specific splicing program controls alternative 3′ UTR isoform selection.Figure 3SAM68-Specific Splicing of Alternative 3′ UTR Exons in the Nervous SystemThe usage of alternative last exon (ALE) or alternative polyadenylation (APA) of candidate RNA substrates was validated by RT-qPCR analysis using adult midbrains from WT, *Sam68*^KO^, *Slm1*^KO^, and *Slm2*^MT^ mice. Fold change (FC) and significant differences were compared with WT mice. The threshold cycle (CT) value of total transcripts was normalized to that of *Gapdh,* whereas the relative quantification (RQ) value of each alternative isoform was normalized to that of each total mRNA (n = 3--6 animals per genotype).(A) ALE: Three genes, *Cp* (Ceruloplasmin), *Pcdh15* (Protocadherin 15), and *Lrrcc1* (leucine-rich repeat and coiled-coil domain-containing protein 1).(B) ALE with alternative 5′ splice sites: Three genes, *Dlgap1* (disk large-associated protein 1), *Il1rap* (interleukin-1 receptor accessory protein), and *Pcdh17* (protocadherin 17).(C) Alternative polyadenylation type (APA): Two genes, *Fbxl3* (F-box/LRR-repeat protein3) and *Sema3e* (semaphorin 3e). Data are presented as the mean ± SEM. Significance is indicated as follows: \*\*\*p \< 0.001; \*\*p \< 0.01; \*p \< 0.05; Student\'s t test.

To further investigate the ALE choice by SAM68, we focused on alternative splicing of *Il1rap* (ALE with alternative 5′ splice site), *Pcdh15* (ALE), *Cp* (ALE), and *Glra3* (ALE). The RT-qPCR analyses revealed that short-form (SF) variants of *Il1rap*, *Pcdh15, Cp*, and *Glra3* including proximal 3′ UTR exons were dramatically increased in the midbrain of *Sam68* ^KO^ and *Sam68*/*Slm1* ^DKO^ mice, whereas the long-form (LF) variant was reciprocally reduced ([Figures 4](#fig4){ref-type="fig"}A--4D, [S4](#mmc1){ref-type="supplementary-material"}, and [S5](#mmc1){ref-type="supplementary-material"}A). Notably, whereas \>90% of *Il1rap* transcripts account for an LF variant in WT mice, \>50% of these transcripts were occupied by the atypical SF variant in *Sam68* ^KO^ and *Sam68*/*Slm1* ^DKO^ mice ([Figure 4](#fig4){ref-type="fig"}C). By contrast, knockout of *Slm1* did not affect any isoform levels of these transcripts and did not have additive effects with loss of SAM68 ([Figures 4](#fig4){ref-type="fig"}A--4D and [S4](#mmc1){ref-type="supplementary-material"}). In addition, the isoform alteration in other analyzed transcripts as shown in [Figure 3](#fig3){ref-type="fig"} (*Lrrcc1*, *Pcdh17*, *Dlgap1*, *sema3e,* and *Fbxl3*) also had no additive effects with the double knockout ([Figures S5](#mmc1){ref-type="supplementary-material"}B--S5D). Thus, we confirmed that these ALE selections are specifically controlled by SAM68. Interestingly, at the protein level, inclusion of *Il1rap* exon 8b, *Pcdh15* exon 26b, *Cp* exon 17, and *Glra3* exon 4b results in production of soluble forms, lacking transmembrane domains or glycosylphosphatidylinositol anchor ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Indeed, when these soluble-form variants were expressed in HEK293T cells, significant amounts of protein products were detected in the cultured medium ([Figure S6](#mmc1){ref-type="supplementary-material"}B). The majority of *Il1rap*, *Pcdh15*, *Cp*, and *Glra3* transcripts are LF variants encoding transmembrane proteins in WT brains ([Figures 4](#fig4){ref-type="fig"}A--4D and [S4](#mmc1){ref-type="supplementary-material"}). There are three ALEs in *Il1rap*, which produce two transmembrane (isoforms 1 and 3) and one soluble isoform (isoform 2) ([Figure 4](#fig4){ref-type="fig"}E, illustration). Consistent with the altered ALE selection at the transcript level, protein analysis by parallel reaction monitoring exhibits significant reduction in transmembrane protein isoform 1 in *Sam68* ^KO^ brains relative to overall *Il1rap* protein levels (Isoform 1, 2, 3 \[total\]) ([Figure 4](#fig4){ref-type="fig"}E). These results indicate that aberrant ALE selection of these transcripts in *Sam68* ^KO^ causes marked conversion into atypical secreted type of proteins in the nervous system.Figure 4*Sam68*^KO^ Causes Atypical Long-to-Short Isoform Conversion of *Il1rap* and *Cp* via Aberrant Usage of ALEs(A and B) Schematic illustration of alternative exon choice at *Il1rap* exon 8 and *Cp* at exon 13 (top panel) and the representative gel images of semi-quantitative RT-PCR with these 3′ UTR exon choices in midbrains from WT, *Slm1*^KO^, and *Sam68/Slm1*^DKO^ mice (bottom panel). (A) Exon 8b on *Il1rap* and (B) exon 13 on *Cp*.(C and D) Relative levels of total mRNA and two alternative isoforms (LF and SF variants) and abundance ratio of SF (red) to LF (blue) between midbrains from WT, *Sam68*^KO^, *Slm1*^KO^, and *Sam68/Slm1*^DKO^ mice by RT-qPCR. The RQ value of total transcripts was normalized to that of *Gapdh,* whereas the RQ value of each alternative isoform was normalized to that of the total transcripts. For the abundance ratio of SF to LF, the percentage of the SF variant was largely estimated from the CT value (CT^*SF*^) directly compared with that of LF (CT^*LF*^) at the same threshold set for the CT value. RQ^*LF*^ + RQ^*SF*^ values for the total transcript level were set to 100%. RQ value of two transcripts was normalized to that of *Gapdh;* (C) *Il1rap* (D) *Cp* (n = 3--6 animals per genotype).(E) Quantification of IL1RAP protein isoforms by parallel reaction monitoring (PRM). To quantify low-abundant protein isoforms, heavy reference peptides for Isoform 1/2/3 (total), Isoform 1, and Isoform 3 of IL1RAP were used in PRM-liquid chromatography-mass spectrometry. Plots show normalized endogenous (light) to reference (heavy) peak intensities of WT and *Sam68*^KO^ hippocampal samples (n = 5 per genotype) or average changes between genotypes for Isoform 1 and 3 (Isoform 1/2/3 \[total\] set as reference). Data are presented as the mean ± SEM. Significance is indicated as follows: \*\*\*p \< 0.001; \*\*p \< 0.01; \*p \< 0.05. One-way ANOVA followed by Bonferroni\'s test.

Soluble IL1RAP Influences Synaptogenic Signaling through Transsynaptic IL1RAP-PTPδ Interaction {#sec2.3}
----------------------------------------------------------------------------------------------

Our data indicated that single loss of SAM68 caused aberrant ALE selection of *Il1rap*, *Pcdh15*, and *Glra3* in *Sam68* ^KO^, resulting in marked conversion into atypical secreted type of proteins in the nervous system. Therefore, we then tested the influence of short/secreted isoforms on neuronal functions. A previous study revealed that IL1RAP and the paralog IL1RAP-like 1 (IL1RAP-L1) organize excitatory synapses through transsynaptic interaction with the protein tyrosine phosphatase δ (PTPδ), a member of the presynaptic cell adhesion molecule, in the nervous system ([@bib53], [@bib52]) ([Figure 5](#fig5){ref-type="fig"}A). We examined the mRNA expression of *Il1rap* and of the related molecules in various brain regions and the developing cortex. The transcripts were ubiquitously expressed in whole brain tissues and throughout development ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B). In addition, ALE choice of *Il1rap* in *Sam68* ^KO^ and *Sam68*/*Slm1* ^DKO^ mice was altered at the same level between the cortex, midbrain, and cerebellum ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Here, we tested the effect of soluble IL1RAP (sIL1RAP) on IL1RAP-induced presynaptic organization and PTPδ-induced postsynaptic organization. To this end, we employed a co-culture system wherein primary cerebellar neurons are combined with non-neuronal cells expressing a single synaptogenic molecule ([@bib39]) ([Figures 5](#fig5){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}D). Cerebellar culture is a highly homogeneous neuron culture, which is appropriate for this assay. IL1RAP-hemagglutinin (HA)-expressing HEK293T cells triggered robust levels of presynaptic differentiation, as measured by recruitment of the presynaptic marker synaptobrevin (VAMP2) ([Figure S7](#mmc1){ref-type="supplementary-material"}E left). By contrast, co-expression with sIL1RAP-HA in HEK293T cells or introduction of sIL1RAP-HA into the cultured neurons with lentivirus significantly reduced the recruitment of the presynaptic marker, demonstrating the competitive effect of sIL1RAP on synapse organization mediated by IL1RAP-PTPδ interaction. The paralog IL1RAP-L1-expressing HEK293T cells also triggered presynaptic differentiation ([Figure S7](#mmc1){ref-type="supplementary-material"}E middle). Similar to IL1RAP, co-expression with sIL1RAP-HA in HEK293T cells significantly reduced IL1RAP-L1-induced recruitment of the presynaptic marker ([Figure S7](#mmc1){ref-type="supplementary-material"}E middle) but did not affect neuroligin-1-induced recruitment ([Figure S7](#mmc1){ref-type="supplementary-material"}E right), confirming the competitive effect of sIL1RAP on other PTPδ-mediated synapse organization. We next examined the influence of sIL1RAP on postsynaptic recruitment onto PTPδ-expressing HEK293T cells when sIL1RAP is co-expressed. Co-culture assay showed that PTPδ-expressing HEK293T cells induced postsynaptic differentiation, as measured by recruitment of the postsynaptic marker PSD95 ([Figure 5](#fig5){ref-type="fig"}C). Co-expression with sIL1RAP-HA in HEK293T cells also significantly affected PTPδ-induced recruitment of the postsynaptic marker, but did not influence NRX1β-induced recruitment. Synaptogenic activity was severely reduced when co-cultured with *Il1rap* knockdown cerebellar neurons ([Figure S7](#mmc1){ref-type="supplementary-material"}F), confirming that PTPδ-induced post-synaptogenic activity of cerebellar neurons might be largely dependent on transsynaptic interaction with IL1RAP rather than the other partner (e.g., IL1RAP-L1) in cerebellar neurons. We then tested PTPδ-induced synaptogenic activity on a co-culture system combined with *Sam68* ^KO^ neurons. We found that PTPδ-induced postsynaptic assembly in *Sam68* ^KO^ neurons was significantly lower than in WT neurons, whereas NRX1β-induced assembly was comparable between WT and *Sam68* ^KO^ neurons ([Figure 5](#fig5){ref-type="fig"}D). Therefore, these results suggest that proper ALE selection of *Il1rap* by SAM68 is required for synaptogenic signaling through transsynaptic IL1RAcP/IL1RAP-L1-PTPδ interaction.Figure 5Soluble IL1RAcP Disturbs PTPδ-Induced Synaptogenic Signaling and IL-1-Mediated NMDAR Function in the Nervous System(A) Illustration of excitatory synapse organization through synaptic interaction of IL1RAP and the related-protein IL1RAP-L1 with PTPδ, and IL-1-induced potentiation of NMDAR-mediated calcium influx through interaction with IL-1 receptor (IL1R) in the CNS.(B) Schematic illustration of neuron-HEK293T cell co-culture assay. To examine IL1RAP-mediated postsynaptic assembly, HEK293T cells expressing PTPδ or neurexin-1β (NRX1β)-HA were co-cultured with cerebellar neurons (DIV10-14).(C and D) Soluble IL1RAP (sIL1RAP) disturbs PTPδ-induced synaptogenic signaling. Postsynaptic assembly on HEK293T cells was detected by immunostaining with postsynaptic marker, PSD-95. (C) HEK293T cells expressing PTPδ or NRX1β-HA with or without sIL1RAP-HA (ratio 1:1). (D) HEK293T cells expressing PTPδ or NRX1β were co-cultured with cerebellar granule neurons from WT or *Sam68*^KO^ cerebella (n = 23--34 cells/each group in \>10 separated fields \[see the number on each graph column\]) Scale bar, 5 μm.(E and F) Calcium imaging with Fluo-4 AM in cultured hippocampal neurons. Soluble IL1RAP disturbs IL-1-induced potentiation of calcium influx mediated via NMDARs. Intracellular calcium levels were measured by Fluo-4 intensity. Quantification of intracellular calcium level at 1 min before NMDA stimulation (Pre) and at 0, 2, and 10 min after stimulation. (E) The traces (left) and quantification (right) of the relative intracellular calcium level in control neurons, *Il1rap* knockdown neurons, and sIL1RAP-HA-expressing neurons with lentiviral infection (control, n = 130 fields; *Il1rap* knockdown, n = 50 fields; sIL1RAP-HA expressing, n = 30 fields, in three independent experiments). (F) The traces (left) and quantification (right) of the relative intracellular calcium level in wild-type, *Sam68*^KO^, and *Slm1*^KO^ neurons (wild-type, n = 50 fields; *Sam68*^KO^, n = 50 fields; *Slm1*^KO^ expressing, n = 40 fields, in three independent experiments). Data are presented as the mean ± SEM. Significance is indicated as follows: \*\*p \< 0.01; \*p \< 0.05. Student\'s t test in (C and D); one-way ANOVA followed by Dunnett\'s test in (E and F).

Soluble IL1RAP Disturbs IL-1-Induced Ca^2+^ Influx Mediated through NMDAR Activation {#sec2.4}
------------------------------------------------------------------------------------

Reportedly, interleukin (IL)-1 mediates not only inflammatory activity in pathological conditions but also long-term potentiation and memory formation in physiological situations by interaction with the IL-1 receptor (IL1R1) ([@bib51]). Such effects of IL-1 are mediated by IL1RAP. IL1RAP governs IL-1β-mediated *N*-methyl-D-aspartic acid (NMDA) receptor (NMDAR) activation through NR2A phosphorylation by Src family kinases in the hippocampal neurons ([Figure 5](#fig5){ref-type="fig"}A) ([@bib14]). Actually, we confirmed that IL-1 and IL-1R1 transcripts were expressed in cortical and hippocampal regions ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B). Therefore, to test whether aberrant usage of *Il1rap* ALE could influence NMDAR-dependent plasticity, we examined the effect of sIL1RAP on NMDAR-dependent Ca^2+^ influx mediated through IL-1 signaling in the cultured hippocampal neurons. As NMDA (20 μM)-induced Ca^2+^ influx is potentiated at a low concentration of IL-1β (0.01 ng/mL) ([@bib14]), we performed intracellular Ca^2+^ imaging using Fluo-4 AM in cultured hippocampal neurons under similar experimental conditions, as previously reported ([@bib14]). We observed elevation of Ca^2+^ level, as measured by fluorescence of Fluo-4 in control neurons for a few minutes after NMDA application in the presence of 0.01 ng/mL of IL-1β ([Figure 5](#fig5){ref-type="fig"}E). Consistent with the previous report, Ca^2+^ elevation was significantly reduced in *Il1rap* knockdown neurons. In line with the knockdown effect, the Ca^2+^ elevation was significantly lower in sIL1RAP-HA-expressing neurons ([Figure 5](#fig5){ref-type="fig"}E). We confirmed the neuronal secretion of sIL1RAP-HA from cultured hippocampal neurons ([Figure S7](#mmc1){ref-type="supplementary-material"}G). We further tested the NMDAR-dependent plasticity in *Sam68* ^KO^ hippocampal neurons. Notably, Ca^2+^ elevation was significantly lower in *Sam68* ^KO^ neurons, but not in *Slm1* ^KO^ ones ([Figure 5](#fig5){ref-type="fig"}F). These results indicate that sIL1RAP impairs IL-1-induced Ca^2+^ influx mediated through NMDAR activation by antagonizing neuronal IL-1 signaling.

SAM68 Directly Binds to the Cryptic Polyadenylation Signal Sequence on Intron 8 of Il1rap {#sec2.5}
-----------------------------------------------------------------------------------------

To address the molecular mechanism by which SAM68 targets the significant number of ALEs, we attempted to identify the recognition element of SAM68 for ALE splicing. Reportedly, the canonical poly(A) signal (PAS) sequences (AAUAAA) are optimal binding sites for SAM68 ([@bib13], [@bib54]). A recent study suggested that SAM68 masks this intronic PAS to prevent premature termination of the transcript through aberrant alternative polyadenylation ([@bib24]). Therefore, to identify the cryptic PAS at the intronic sequence of *Il1rap*, we performed 3′ rapid amplification of cDNA ends analysis from *Sam68* ^KO^ brains and detected two major transcripts of *Il1rap* exon 8b ([Figure S8](#mmc1){ref-type="supplementary-material"}A, arrows). The sequence analyses confirmed that the two transcripts were the full-length of exon 8b (exon 8b LF) and shorter ones (exon 8b SF) ([Figures 6](#fig6){ref-type="fig"}A and [S8](#mmc1){ref-type="supplementary-material"}B). Actually, we found that the 3′ UTR of exon 8b contains two putative PAS sites (PAS1 and PAS2) ([Figure 6](#fig6){ref-type="fig"}A, blue boxes). Here, RNA-seq showed that most of the transcript reads were terminated around PAS1 in *Sam68*/*Slm1* ^DKO^ brains ([Figure 6](#fig6){ref-type="fig"}B). Although an RT-qPCR study detected the transcripts of exon 8b LF in *Sam68* ^KO^ brains by using LF-unique primer set (primer 3) when compared with those of WT, it appeared that the amount was very small (only 2-fold higher compared with that of WT) ([Figure S8](#mmc1){ref-type="supplementary-material"}C). These data indicate that the major transcripts in *Sam68* ^KO^ brains are exon 8b SF. Indeed, the sequences of PAS1 were completely conserved between humans and mice ([Figure S8](#mmc1){ref-type="supplementary-material"}D). Therefore PAS1 is possibly the most actionable in the absence of SAM68.Figure 6SAM68 Directly Binds to Cryptic PAS in the Intron 8 of *Il1rap*(A) The full-length cDNA sequence of *Il1rap* exon 8 (left), and the schematic illustration of the two major transcripts in *Sam68*^KO^ brains (*exon 8b* SF and *exon 8b* LF) (right). Green indicates the coding exon region, blue shows putative PAS sites on the 3′ UTR.(B) RNA-seq on *Il1rap* exon 8b in wild-type and *Sam68/Slm1*^DKO^ brains. Arrowheads represent two putative PAS sites (PAS1 and PAS2).(C--F) Mapping of SAM68 recognition elements in *Il1rap.* (C and D) UV cross-linked RNA immunoprecipitation (CLIP) assay. (C) Positions of three primer sets used for the assay. (D) The representative gel loading images of the CLIP assay using anti-SAM68 antibody and the quantification by RT-qPCR analysis (n = 3 brains). (E and F) Biotinylated RNA pull-down experiments. (E) Biotinylated RNA oligonucleotide probes covering the 3′ UTR sequence of *Il1rap* exon 8b used in pull-down experiments. The PAS a/c mut probe contains two nucleotide changes (red). (F) The pull-down experiments with mouse adult brain extracts. Bound proteins were detected by western blot analysis with anti-SAM68 and anti-Rbfox1 antibodies. SAM68 binding was quantified by densitometric scanning of western blot signals (n = 5).Data are presented as the mean ± SEM. Significance is indicated as follows: \*\*\*p \< 0.001; \*\*p \< 0.01; \*p \< 0.05. Student\'s t test.

Expectedly, UV cross-linked RNA immunoprecipitation with SAM68 antibody in WT brains showed the assembly of SAM68 near PAS1, whereas binding in other regions was much weaker ([Figures 6](#fig6){ref-type="fig"}C and 6D). To further test the direct binding to PAS1, we examined the binding of SAM68 to synthetic RNA oligonucleotides spanning 30 bases of the PAS1 region ([Figure 6](#fig6){ref-type="fig"}E). The *Il1rap* 8b UTR WT probe (PAS1 WT) yielded efficient binding of endogenous SAM68 from brain extracts in the pull-down assays ([Figure 6](#fig6){ref-type="fig"}F). Furthermore, mutation of two nucleotides in a presumptive SAM68-binding PAS site (PAS1 a/c mut) significantly reduced the recovery of SAM68 ([Figures 6](#fig6){ref-type="fig"}E and 6F), demonstrating that endogenous SAM68 can directly recognize the PAS1 sequence. Under the same conditions, the other RBP, Rbfox1, was not recovered in the precipitates. Therefore, these data suggest that SAM68 regulates ALE selection through direct binding to the cryptic PAS in intron 8 of WT brains.

Tissue-Specific SAM68 Expression Determines ALE Selection in Spatial Fashion {#sec2.6}
----------------------------------------------------------------------------

Given that a significant number of SAM68-targeted transcripts could be expressed in tissues other than the brain, it would be of interest to explore how SAM68-dependent ALE selection is controlled in those other tissues. Therefore, we examined the expression profiles of *Il1rap, Cp, Pcdh15*, and *Lrrcc1* in various tissues. We observed that transcripts of *Il1rap, Cp*, and *Lrrcc1* were detected ubiquitously ([Figure S9](#mmc1){ref-type="supplementary-material"}A). On the other hand, expression of SAM68 exhibited a tissue-specific pattern ([Figure S9](#mmc1){ref-type="supplementary-material"}B). In particular, SAM68 expression appears to be very subtle in the liver. RT-qPCR also showed low expression of not only *Sam68* but also *Slm1* in the liver at the transcript level ([Figure S9](#mmc1){ref-type="supplementary-material"}C). We then examined the ratio of *Il1rap* and *Cp* splicing isoforms (LF versus SF) in several tissues. The ratio was highly variable among tissues ([Figure 7](#fig7){ref-type="fig"}A). In contrast to the brain, both major transcripts were the SF variant in the liver, in which SAM68 expression is very low. Indeed, we found that the amount of SAM68 is inversely correlated with the abundance of the SF variant (*Il1rap*, R^2^ = 0.85, p = 0.008; *Cp*, R^2^ = 0.86, p = 0.04, [Figure 7](#fig7){ref-type="fig"}B). We also observed that the amount of the *Il1rap* SF variant was significantly increased in the *Sam68* ^KO^ lung and brain compared with the WTs ([Figure 7](#fig7){ref-type="fig"}C), whereas ectopic expression of SAM68 in primary liver cell culture significantly reduced the SF variant ([Figure 7](#fig7){ref-type="fig"}D). These results showed that ALE selection of these SAM68 targets is highly dependent on the expression dose of SAM68.Figure 7The Distinct Amount of SAM68 Is Responsible for Proper 3′ UTR Isoform Selection of *Il1rap* and *Cp* in the Nervous and Non-nervous Systems(A) Abundance ratio of SF to LF in the brain, lung, intestine, spleen, and liver of WT mice. For the abundance ratio of SF to LF, the percentage of the SF variant was largely estimated from the CT value (C~T~^*SF*^) directly compared with that of LF (C~T~^*LF*^) at the same threshold set for the CT value. RQ^*LF*^ + RQ^*SF*^ values for total *Il1rap* were set to 100%. RQ value of two transcripts was normalized to that of *Gapdh* (n = 3--4 animals per group).(B) Reciprocal correlation between SAM68 level and production of *Il1rap* and *Cp* SFs. SAM68 was quantified by western blot analysis. The value for the cerebellum was set to 1.0. Correlation coefficients between SAM68 and the SF transcript of *Il1rap* and *Cp* (right) were determined in the scatterplot analysis. The gray lines in the scatterplot are the 95% confidence limit of the best fit line.(C) Quantification of the SF variant of *Il1rap* between brain and non-neuronal tissues (lung, intestine, liver, and spleen) from WT and *Sam68*^KO^ mice by RT-qPCR. The RQ value of total transcripts was normalized to that of total *Il1rap* (n = 3 animals per genotype). RQ values for wild-type brain (Cb) were set to 1.0.(D) Quantification of the SF variant of *Il1rap* between the primary liver cell cultures and the ones in which SAM68 was ectopically expressed with lentiviral infection. The RQ value of total transcripts was normalized to that of *Gapdh.* The RQ value of SF transcripts was normalized to that of total *Il1rap* (n = 3 cultures per group).(E) Representative images of western blot analysis with the α-SAM68 antibody. Human hepatoma cell line, HepG2, cells aberrantly express SAM68 at high level.(F) Low production of the *Il1rap* SF variant in HepG2 cells. The abundance ratio of SF to LF was compared between the normal mouse liver and HepG2 cells (n = 3--4 cultures per group).(G) Restoration of aberrant ALE selection in HepG2 cells by knockdown of SAM68. Knockdown of aberrantly expressing SAM68 partially but significantly increased the level of the *Il1rap* SF isoform in HepG2 cells The RQ value of SF transcripts was normalized to that of total *Il1rap* (n = 3--4 cultures per group).(H and I) Model of tissue-specific isoform selection of *Il1rap* and *Cp* through usage of ALEs between the brain and liver by physiologically expressed SAM68. (H) The neurons strongly express SAM68, so that they dominantly produces the membrane forms. In contrast to the brain, secreted forms lacking transmembrane domain or glycosylphosphatidylinositol anchor are abundantly produced in the liver. (I) SAM68-specific ALE selection is required for the organization of IL1RAP-dependent excitatory synapses through transsynaptic interaction with PTPδ in the nervous system. On the other hand, absence of SAM68 causes the release of IL1RAP into the plasma, which could be necessary for homeostatic control of IL1-mediated inflammation.Data are presented as the mean ± SEM. Significance is indicated as follows: \*\*\*p≪0.001; \*p \< 0.05; Student\'s t test.

Furthermore, we observed that although SAM68 is not expressed in the normal mouse liver, it was strongly expressed in a human hepatocarcinoma cell line, i.e., HepG2 cells ([Figure 7](#fig7){ref-type="fig"}E). In association with the strong expression of SAM68, we found that the ratio of the *Il1rap* SF variant in HepG2 cells was markedly lower (\<40%), compared with that in the normal mouse liver ([Figure 7](#fig7){ref-type="fig"}F). To verify whether the low amount of the *Il1rap* SF variant in HepG2 cells is due to the aberrant expression of SAM68 in carcinoma cells, we examined the knockdown effect of human SAM68 (hSAM68) on the ratio of *Il1rap* splicing variants in HepG2 cells. We found that knockdown of hSAM68 partially, but significantly, increased the *Il1rap* SF variant ([Figure 7](#fig7){ref-type="fig"}G). These results further suggest that SAM68 is a dominant regulator for ALE selection of *Il1rap* throughout the whole tissue. Thus, the absence of SAM68 causes a long-to-short isoform switch of the neuronal targets in non-neuronal tissues ([Figure 7](#fig7){ref-type="fig"}H), indicating that the SAM68 expression level is critical for the tissue-specific selection of alternative 3′ UTR isoforms through ALE choice. Indeed, whereas atypical sIL1RAP could impair PTPδ-mediated synapse organization in the nervous system ([Figure 5](#fig5){ref-type="fig"}), physiological sIL1RAP in plasma plays a homeostatic role in IL-1 signaling by antagonizing the interaction with IL-1R1 in the immune system ([@bib19], [@bib40]). Therefore, SAM68-dependent ALE selection could be necessary to exert distinct functions of ubiquitously expressed molecules between the nervous and the non-nervous systems ([Figure 7](#fig7){ref-type="fig"}I).

Discussion {#sec3}
==========

Distinct Alternative Splicing Activity between SAM68 and the Related Proteins SLMs {#sec3.1}
----------------------------------------------------------------------------------

We showed that neuronal alternative splicing by STAR family proteins is an important mechanism for functional diversification. Here, we conducted transcriptomic analyses using *Slm1* ^KO^ and *Sam68*/*Slm1* ^DKO^ brains and showed a different splicing activity between SAM68 and SLM1. This study focused on the neuronal isoform selection in 3′ UTR by SAM68 and demonstrated their functional aspects through the identification of a novel target IL1RAP in neurons ([Figure 5](#fig5){ref-type="fig"}). Very recently, two articles also elucidated the interaction between SAM68 and U1 small nuclear ribonucleoprotein particle (snRNP) as a global mechanism underlying ALE regulation by SAM68 ([@bib34], [@bib41]), supporting our findings in the CNS. U1 snRNP prevents premature transcript termination by inhibition of cryptic PASs ([@bib5], [@bib20]). Therefore, our findings on ALE selection in CNS also might be largely explained by the interaction with U1 snRNP. However, given that the U1 binding-like sequences were not observed around cryptic PAS1 on *Il1rap* (see [Figure S8](#mmc1){ref-type="supplementary-material"}), additional mechanism also could be possible. Considering the direct binding to cryptic PAS in WT brains ([Figure 6](#fig6){ref-type="fig"}), another possibility is that SAM68 may block the recruitment of such 3′ end machineries on the PAS as the CPSF and CstF to prevent the proximal termination of *Il1rap* pre-mRNA. ALE selection is related to alternative polyadenylation; such 3′ end formation factors have been shown to play a role in alternative splicing ([@bib31]).

In addition to the difference in splicing activities between SAM68 and SLM1, this study also suggested a difference between SLM1 and another family protein, SLM2. We newly mapped the entire SLM1-dependent program and revealed that a significant number of exons seemed to be altered in *Slm1* ^KO^ brains ([Figure 1](#fig1){ref-type="fig"} and [Table S2](#mmc3){ref-type="supplementary-material"}), whereas SLM2 encodes a highly selective alternative splicing program that regulates only a few synaptic molecules ([@bib45]). Regardless of the high structural homology between SLM1 and SLM2 ([@bib9]), the large functional difference between the two closely related proteins is very surprising. We previously showed that SAM68 can heteromerize with SLM1, but not with SLM2 ([@bib17]), which suggests that endogenous SLM2 ordinarily exists as a homodimer. Thus dimer formation is intrinsically different between SLM1 and SLM2. Increased RNA affinity through dimer formation is a critical parameter enabling SLM proteins to select their functional targets with the transcriptome ([@bib13]). Therefore, one possibility is that the structural difference in dimer interface between SLM1 and SLM2 complexes results in distinct splicing programs. However, numerous questions on the functional difference between STARs remains to be addressed in future studies.

Critical Role of Proper ALE Selection of Il1rap between the Nervous and Other Systems by Distinct SAM68 Expression Level {#sec3.2}
------------------------------------------------------------------------------------------------------------------------

This study revealed that SAM68 is a dominant factor for ALE selection of *Il1rap* in the nervous system. mIL1RAP is necessary for organizing excitatory synapses through transsynaptic interaction with PTPδ in the CNS ([@bib52]). This study demonstrated that, in addition to the significant reduction in mIL1RAP ([Figure 4](#fig4){ref-type="fig"}), the competitive effect of sIL1RAP could accelerate the impairment in PTPδ-mediated synapse organization ([Figures 5](#fig5){ref-type="fig"}A--5D). Reasonably, the competitive effect is supported by the X-ray structural analysis showing that the Ig domains of IL1RAP and PTPδ are the elements responsible for the heterophilic interaction ([@bib50]). Both IL1RAP and PTPδ have several transsynaptic binding partners. PTPδ organizes synapses through interaction with IL1RAP-L1 and Slitrk3 ([@bib42], [@bib53]). In addition to IL1RAP, because we demonstrated the competitive effect of sIL1RAP on presynapse assembly onto HEK293T cells expressing another paralog, IL1RAP-L1, on co-culture assays ([Figure S7](#mmc1){ref-type="supplementary-material"}E), sIL1RAP may influence several related transsynaptic types of synaptogenic signaling in the CNS. We also revealed that sIL1RAP significantly affects IL-1β-induced NMDAR activation in hippocampal neurons ([Figures 5](#fig5){ref-type="fig"}E and 5F). Thus, this study suggests that proper ALE usage by SAM68-specific splicing is critical for both aspects of synaptic organization and plasticity in the CNS.

In contrast to the brain, the liver is thought to be a major source of sIL1RAP, which is suggested to play an important role in the homeostasis of IL-1 signaling by antagonizing the interaction of IL1RAP with IL-1R1 in the immune system ([@bib19], [@bib40]). The reduced level of physiological sIL1RAP in the plasma is in fact implicated in several diseases ([@bib7], [@bib30]). Thus, tissue-specific SAM68 expression could play a critical role in distinct functions of ubiquitously expressed proteins between the nervous and non-nervous systems through ALE selection ([Figures 7](#fig7){ref-type="fig"}H and 7I).

Regulatory Functions of the SAM68 Splicing Program Dedicated to Alternative 3′ UTR Isoform Diversity {#sec3.3}
----------------------------------------------------------------------------------------------------

Thousands of mammalian genes encode alternatively spliced isoforms in their 3′ UTR ([@bib33], [@bib44]). Here, we demonstrated that SAM68 is required for the spatial control of alternative 3′ UTR isoforms between the nervous and the other systems by identification of new SAM68 targets ([Figure 7](#fig7){ref-type="fig"}). Importantly, GO analyses implied that SAM68 targets the 3′ UTR exons of multiple transcripts that encode neuronal membrane or secreted proteins ([Figures 1](#fig1){ref-type="fig"}E and [2](#fig2){ref-type="fig"}D). The biochemical studies indeed found drastic shift to short isoforms by aberrant ALE selection in *Sam68* ^KO^ brains, which could result in membrane-to-secreted isoform conversion at the protein level. Thus the findings strongly suggest that SAM68 is a key regulator for shaping the diversity of neuronal 3′ UTR isoforms in the nervous system.

The other intriguing point regarding alternative 3′ UTR selection is the molecular control at the transcript level. This study also found that SAM68 regulates not only ALE but also APA ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}C), which alters the length of the 3′ UTR itself. Such alternative 3′ UTR diversity by APA and ALE contributes to the posttranscriptional processes such as translation, mRNA stability, and subcellular localization during development ([@bib10], [@bib43]) and dendritic localization and the local translation in the nervous system ([@bib46]). Therefore, it would be of interest to explore how the ALE/APA-mediated mechanism by SAM68 contributes to molecular functions at the transcript level in a future study. Overall, although the mechanism by which a specific subset of 3′ UTR exons is controlled by SAM68-specific splicing should be examined, our findings could provide a general principle underlying the control of alternatively spliced 3′ UTR isoforms.

Limitations of Study {#sec3.4}
--------------------

In this study, we performed transcriptomic analysis using SAM68 knockout and SAM68/SLM1 double-knockout midbrains and revealed a different alternative splicing activity between SAM68 and SLM1; we characterized alternative 3′ UTR selection by SAM68-specific splicing in the nervous system. However, the open questions on the mechanism underlying the differential splicing activity between SAM68 and the related family proteins remains to be addressed in future studies.

Our findings extend the understanding on the neuronal function of SAM68, in particular through the identification of IL1RAP as a new SAM68 target. However, the physiological consequences were mainly obtained by neuronal culture system. Further studies are needed to confirm the functional relevance *in vivo*.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

The data presented in this article have been deposited in NCBI\'s Gene Expression Omnibus and are accessible through GEO Series accession number [GSE110258](ncbi-geo:GSE110258){#intref0010}.
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Document S1. Transparent Methods and Figures S1--S9Table S1. Summary of SAM68/SLM1-Regulated Genes, Related to Figure 1Altered genes (threshold set: FC ≥ 2.0, raw probe signal intensity ≥100 in either of the two genotypes, normalized gene expression \> −3) in *Slm1*^KO^ and *Sam68*/*Slm1*^DKO^ mice.Table S2. Summary of SAM68/SLM1-Regulated Exons, Related to Figures 1 and 2Significantly altered exons (threshold set: FC ≥ 2.4, raw probe signal intensity ≥100 in either of the two genotypes, normalized gene expression \> −3, p \< 0.05) in *Slm1*^KO^ and *Sam68*/*Slm1*^DKO^ mice.
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